Phase I/II trial of non-cytotoxic suramin in combination with weekly paclitaxel in metastatic breast cancer treated with prior taxanes
Maryam B. Lustberg(Yale Cancer Center), Charles L. Shapiro(Tisch Hospital), Ewa Mrózek(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Tong Shen(Qingdao University of Science and Technology), Michael R. Grever(The Ohio State University Wexner Medical Center), Donna R. Shiels(The Ohio State University), Yong Wei(The Ohio State University), Bhuvaneswari Ramaswamy(The Ohio State University), M. Guillaume Wientjes(The Ohio State University), Shubham Pant(The University of Texas MD Anderson Cancer Center), Jessie L.‐S. Au(Temple University Hospital), Ling Chen(Guangzhou Institutes of Biomedicine and Health), Michael Berger(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Lisa A. Brenner(University of Colorado Anschutz Medical Campus), Amy S. Ruppert(The University of Texas MD Anderson Cancer Center), R. Jensen(National Cancer Institute)
Cited by 28
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
|Nature|2002|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia
|The Journal of Experimental Medicine|2001|1.1k